Millennium Management Portfolio holdings
Millennium Management is a multistrategy hedge fund firm, started in 1989 by Israel Englander along with Ronald Shear, an acquaintance from the American Stock Exchange who left after six months. Englander remains its principal. It works as a platform: many separate investment teams, each with a portfolio manager given money to trade in a variety of strategies. Its teams research and pick individual companies, run computer-driven strategies, and trade fixed income, commodities and credit. In 2018 it launched a joint venture with WorldQuant, a computer-driven investment firm. Its clients include state and local government bodies and sovereign wealth funds.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.07B |
| 2 |
SpaceX
SPCX
|
+$2.99B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$1.11B |
| 4 |
Microsoft
MSFT
|
+$584M |
| 5 |
Bloom Energy
BE
|
+$547M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.65B |
| 2 |
Marvell Technology
MRVL
|
+$1.16B |
| 3 |
Apple
AAPL
|
+$1.12B |
| 4 |
Sandisk
SNDK
|
+$1.11B |
| 5 |
Micron Technology
MU
|
+$816M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.34% |
| 2 | Technology | 9.51% |
| 3 | Industrials | 7.56% |
| 4 | Financials | 5.78% |
| 5 | Healthcare | 5.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1926
Hyperliquid Strategies Inc
PURR
$1.94B
| $13.4M | ﹤0.01% |
1,705,218
+805,915
| +90% | +$5.96M |
2025 Q4
2 quarters
|
|
1927
Regions Financial
RF
$24.7B
| $13.4M | ﹤0.01% |
443,435
-2,206,404
| -83% | -$61.9M |
2020 Q2
24 quarters
|
|
1928
Pfizer
PFE
$174B
| $13.4M | ﹤0.01% |
556,133
+459,769
| +477% | +$12M |
2017 Q1
37 quarters
|
|
1929
Darling Ingredients
DAR
$8.26B
| $13.4M | ﹤0.01% |
245,056
-2,639,156
| -92% | -$158M |
2014 Q4
46 quarters
|
|
1930
PUT
SELLAS Life Sciences
SLS
$1.8B
| $13.4M | ﹤0.01% |
906,000
+280,000
| +45% | +$1.93M |
2026 Q1
1 quarter
|
|
1931
NNN REIT
NNN
$8.05B
| $13.4M | ﹤0.01% |
287,362
-3,599
| -1% | -$161K |
2014 Q4
46 quarters
|
|
1932
Weis Markets
WMK
$1.98B
| $13.3M | ﹤0.01% |
170,001
-22,653
| -12% | -$1.66M |
2025 Q2
4 quarters
|
|
1933
Inventiva
IVA
$945M
| $13.3M | ﹤0.01% |
3,512,174
+524,561
| +18% | +$2.52M |
2025 Q3
3 quarters
|
|
1934
CALL
Marriott International
MAR
$110B
| $13.3M | ﹤0.01% |
35,800
-60,700
| -63% | -$22.4M |
2020 Q3
23 quarters
|
|
1935
Corcept Therapeutics
CORT
$8.32B
| $13.3M | ﹤0.01% |
152,567
-406,180
| -73% | -$24.5M |
2021 Q1
21 quarters
|
|
1936
Twilio
TWLO
$32.4B
| $13.3M | ﹤0.01% |
64,265
-571,387
| -90% | -$101M |
2020 Q1
25 quarters
|
|
1937
MDU Resources
MDU
$4.14B
| $13.3M | ﹤0.01% |
624,798
+290,833
| +87% | +$6.33M |
2017 Q3
35 quarters
|
|
1938
Vornado Realty Trust
VNO
$6.57B
| $13.2M | ﹤0.01% |
336,992
-477,028
| -59% | -$15.4M |
2022 Q4
14 quarters
|
|
1939
Louisiana-Pacific
LPX
$5.36B
| $13.2M | ﹤0.01% |
+167,832
| New | +$12.4M |
2026 Q2
0 quarters
|
|
1940
Lexeo Therapeutics
LXEO
$267M
| $13.2M | ﹤0.01% |
2,833,622
+1,220,842
| +76% | +$6.6M |
2023 Q4
10 quarters
|
|
1941
Compañía de Minas Buenaventura
BVN
$7.17B
| $13.2M | ﹤0.01% |
450,163
-103,086
| -19% | -$3.5M |
2022 Q4
14 quarters
|
|
1942
CALL
State Street SPDR S&P Retail ETF
XRT
$426M
| $13.2M | ﹤0.01% |
150,000
-100,000
| -40% | -$8.42M |
2024 Q3
7 quarters
|
|
|
1943
PUT
State Street SPDR S&P Retail ETF
XRT
$426M
| $13.2M | ﹤0.01% |
150,000
| – | – |
2023 Q3
11 quarters
|
|
1944
Hexcel
HXL
$6.27B
| $13.1M | ﹤0.01% |
131,349
+81,801
| +165% | +$7.41M |
2021 Q4
18 quarters
|
|
1945
AngloGold Ashanti
AU
$44.4B
| $13.1M | ﹤0.01% |
162,102
-28,304
| -15% | -$2.69M |
2023 Q2
12 quarters
|
|
1946
Praetorian Acquisition Corp
PTOR
$338M
| $13.1M | ﹤0.01% |
+1,320,000
| New | +$13M |
2026 Q2
0 quarters
|
|
1947
Bright Horizons
BFAM
$2.65B
| $13.1M | ﹤0.01% |
184,789
-904,310
| -83% | -$65.4M |
2024 Q2
8 quarters
|
|
1948
CALL
Boston Scientific
BSX
$66.5B
| $13.1M | ﹤0.01% |
306,800
-525,800
| -63% | -$28.6M |
2019 Q3
27 quarters
|
|
1949
CALL
GlobalFoundries
GFS
$22.3B
| $13.1M | ﹤0.01% |
158,800
+6,100
| +4% | +$426K |
2025 Q2
4 quarters
|
|
1950
Albemarle
ALB
$11.1B
| $13.1M | ﹤0.01% |
96,866
-404,101
| -81% | -$71.3M |
2019 Q4
26 quarters
|
|
Similar funds
Millennium Management's Q2 2026 Portfolio in Review
As of Q2 2026, Millennium Management held 6,628 positions worth $276B, up 15% from $240B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management's Q2 2026 filing shows 986 new, 2,006 increased, 2,341 reduced and 833 closed positions. Its largest new stake was SpaceX: 17,604,863 shares worth $2.98B. The largest sale was State Street SPDR Portfolio S&P 500 ETF, an estimated $1.65B.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, up from 54% a quarter earlier, followed by Technology and Industrials.
- Millennium Management's largest Q2 2026 buy was SpaceX: 17,604,863 shares worth $2.98B.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $3.07B increase.
- Millennium Management's biggest Q2 2026 reduction was Marvell Technology, cutting an estimated $1.16B.
- Millennium Management fully exited State Street SPDR Portfolio S&P 500 ETF in Q2 2026, selling an estimated $1.65B.
- Millennium Management's ten largest holdings make up 18% of its $276B portfolio in Q2 2026.
- Millennium Management opened 986 new positions and closed 833 in Q2 2026.
- Millennium Management's portfolio value rose 15% quarter-over-quarter to $276B.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.